Sputnik

Dr. Reddy’s Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in India.

Dr. Reddy’s Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in India.

The Russian Sputnik V vaccine has arrived in India following the nod to Hyderabad-based pharmaceutical company, Dr. Reddy's Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in India.  A video of small containers having the logo of Dr. Reddy's and Sputnik V being unloaded from a vehicle went viral on social media on Wednesday.  When contacted, a senior official of Dr. Reddy's confirmed that the vaccines have arrived in India and said that the clinical trials will also start shortly. This coincides…
Read More
After Pfizer, Sputnik V: Russia says Covid-19 vaccine shows 92% efficacy

After Pfizer, Sputnik V: Russia says Covid-19 vaccine shows 92% efficacy

The Sputnik V vaccine candidate has demonstrated “high efficacy” in interim data, reducing by 92 per cent the possibility that those inoculated would be clinically diagnosed with symptomatic Covid-19, Russian authorities have said. The findings of the trial are not yet peer-reviewed. But they are crucial for India, where the vaccine is being tested onhumans in mid- to late-stage trials by Hyderabad-based Dr Reddy’s Laboratories. The Sputnik V announcement has come two days after American drug major Pfizer released interim information that showed its Covid-19 vaccine with…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.